Actively Recruiting
Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study
Led by Mỹ Đức Hospital · Updated on 2026-03-18
356
Participants Needed
2
Research Sites
92 weeks
Total Duration
On this page
Sponsors
M
Mỹ Đức Hospital
Lead Sponsor
M
My Duc Phu Nhuan Hospital HCMC, Vietnam
Collaborating Sponsor
AI-Summary
What this Trial Is About
The uterus is a dynamic muscular organ that undergoes rhythmic, wave-like contractions known as endometrial peristalsis or endometrial waves. This muscular activity, which is an essential component of natural fertility, presents a nuanced and sometimes contradictory role in the context of assisted reproductive treatments. Endometrial peristalsis refers to the frequency, amplitude, and pattern of myometrial contractions occurring in different reproductive phases. These peristalsis play vital roles in sperm transport, embryo migration, and implantation. Clinical and imaging studies suggest that abnormal patterns or excessive contractility at the time of embryo transfer may disrupt endometrial-embryo synchrony, impair implantation, and increase miscarriage risk. However, most evidence on endometrial peristalsis pertains to fresh embryo transfer cycles, natural conceptions, or pathological contexts, such as adenomyosis or fibroids, with limited insights regarding its effects on different endometrial preparation protocols in frozen embryo transfer (FET). Understanding the dynamics of endometrial peristalsis in this context is clinically important, as inappropriate contractile activity could physically expel the embryo or create a non-receptive environment, ultimately reducing the chances of live birth. Despite its theoretical significance, there is a paucity of robust, prospective data correlating endometrial peristalsis patterns measured around the time of FET with different endometrial preparation protocols with subsequent pregnancy outcomes.
CONDITIONS
Official Title
Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 - 42 years old
- Scheduled for frozen embryo transfer cycles using hormone replacement therapy or natural cycle protocol (true natural cycles or modified natural cycles)
- Transferred no more than two cleavage embryos or one good-quality blastocyst or no more than two poor-quality blastocysts
You will not qualify if you...
- Allergy or contraindications for hormone treatment such as breast cancer or thromboembolic disease
- Use of preimplantation genetic testing, oocyte donation, or in vitro maturation cycles
- Untreated uterine or adnexal abnormalities including intrauterine adhesions, abnormal uterus shape, endometrial polyp, large leiomyoma 5 cm or larger, hydrosalpinx, or endometrial hyperplasia
- Use of uterine relaxants or intralipid infusion during embryo transfer
- Use of GnRH-agonist for downregulation within one month
- Diagnosis of polycystic ovary syndrome (PCOS)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
My Duc Phu Nhuan Hospital
Ho Chi Minh City, Vietnam, 70000
Actively Recruiting
2
IVFMD Phu Nhuan - My Duc Phu Nhuan Hospital
Ho Chi Minh City, Vietnam
Not Yet Recruiting
Research Team
X
Xuyen Thi Ha Le, MD
CONTACT
T
Tuong M Ho, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here